}

The Diagnosis of AUB: Causes and
the Emerging Diagnostic Option

Program 1:A New and Better Standard of Care Than Blind Biopsy for the Diagnosis of Abnormal Uterine Bleeding

Host: Andrea J. Singer, MD 
Guest: Steven R. Goldstein, MD

Recent advances in technology are significantly changing the way physicians evaluate patients with abnormal uterine bleeding (AUB).

Watch Program

Overview

Recent advances in technology are significantly changing the way physicians evaluate patients with abnormal uterine bleeding (AUB). Clinicians must understand the gravity of abnormal uterine bleeding in terms of patient health. One-third of patient visits to the gynecologist are for abnormal bleeding - accounting for more than 70% of gynecologic consults in perimenopausal and postmenopausal women. For younger women between ages 19 and 39, abnormal bleeding most frequently occurs as a result of pregnancy, benign structural lesions, anovulatory cycles in polycystic ovarian syndrome, abnormalities of hormonal contraception, and occasionally even endometrial hyperplasia. 

Join host Dr. Andrea Singer as she welcomes Dr. Steven R. Goldstein to discuss AUB and Endosee, an in-office diagnostic hysteroscopy. Dr. Goldstein is a Professor of Obstetrics and Gynecology at the New York University School of Medicine, immediate Past President of the American Institute of Ultrasound in Medicine, and a clinical practitioner in the Faculty Practice Suites at New York University.


Program 2:Abnormal Uterine Bleeding (AUB): Impact of Direct Visualization for Earlier Diagnosis

Host  Renée Simone Yolanda Allen, MD, MHSc., FACOG
Guest  Abigail Feathers, MD 
Guest  Kevin J. Lee, MD, MSPH, FACOG
 
Guest  Stephen M. Volin, MD

Endometrial biopsy (EMB) has limitations in diagnosing abnormalities within the uterine cavity. If cancer occupies less than 50% of the surface area of the endometrial cavity, the cancer can be missed by a blind EMB alone.

Watch Program

Overview

Endometrial biopsy (EMB) has limitations in diagnosing abnormalities within the uterine cavity. If cancer occupies less than 50% of the surface area of the endometrial cavity, the cancer can be missed by a blind EMB alone. And, EMB alone could potentially miss the diagnosis of focal lesions in up to 18% of patients. In this first discussion of a 2-part series, experts will be discussing the benefits of direct visualization of the uterine cavity at the point-of-care and its benefits to both you and your patients.

Host Dr. Renee Allen welcomes:

  • Abigail Feathers, MD, Fellow of the American College of Obstetricians and Gynecologists (FACOG) and practicing gynecologist at Garrett Regional Medical Center, Oakland, MD.
  • Kevin J. Lee, MD, MSPH, FACOG, practices minimally invasive gynecology and gynecologic endoscopy in Baltimore, MD. Dr. Lee has particular expertise and interest in uterine fibroids, abnormal uterine bleeding, pelvic pain, endometriosis, and health disparities.
  • Stephen M. Volin, MD, founder and managing physician with The Women's Health Group and the Colorado Pelvic Floor and Incontinence Center, instructor with the University of Colorado School of Medicine and Rocky Vista University

Program 3: Endosee: Changing the Work Up of Abnormal Uterine Bleeding

Host  Renée Simone Yolanda Allen, MD, MHSc., FACOG
Guest  Abigail Feathers, MD 
Guest  Kevin J. Lee, MD, MSPH, FACOG
 
Guest  Stephen M. Volin, MD

In this second discussion of a 2-part series, host Dr. Renee Allen welcomes back gynecologic experts as they discuss "Endosee: Changing the Work Up of Abnormal Uterine Bleeding.”

Watch Program

Overview

In this second discussion of a 2-part series, host Dr. Renee Allen welcomes back gynecologic experts as they discuss "Endosee: Changing the Work Up of Abnormal Uterine Bleeding."  They will review their experience on how Endosee benefits their individual practices, the benefits to their patients, and the overall healthcare system. Our medical guest experts are Dr. Abigail Feathers, solo practitioner, Medical and Surgical Gynecologist in Oakland, Maryland; Dr. Kevin J. Lee, minimally invasive GYN surgeon at MedStar Medical Group Women's Health at MedStar Good Samaritan Hospital in Baltimore, Maryland; and Dr. Stephen M. Volin, founder and managing partner of the Women's Health Group in Denver, Colorado.


“Endosee is shifting the paradigm of how we evaluate our patients with abnormal bleeding. It has enabled me to evaluate most of the abnormal bleeding patients right in the office instead of the operating room.”

  • Cynthia Baldwin, MD
  • Halifax OB/GYN Associates
  • Daytona, FL